CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
saline +1 moredrug
Likely dose
saline 5mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01167907
NCT01167907N/ACompleted

Evaluation of a Continuous Saphenous Nerve Block to Supplement a Continuous Sciatic Nerve Block for Postoperative Analgesia Following Ankle Surgery

Wake Forest University Health Sciences·interventional·Posted Jul 22, 2010·Updated Aug 31, 2018

In Brief

A clinical study evaluating 0.2% ropivacaine and saline for Orthopedic Surgery of Lower Extremity. Completed, enrolled 32 participants across 1 site.

Detailed Summary

A nerve block catheter is a small tube placed next to a nerve through a needle, and the needle is then removed. Numbing medicine is dripped through the tube to reduce pain sensation from the nerve. The purpose of this research study is to test whether the placement of a second nerve block catheter, rather than a single injection for the saphenous nerve block will improve pain relief and/or reduce pain medication needed after surgery enough to justify two nerve block catheters. There are two nerves that carry pain sensations from the ankle, the large (sciatic) nerve and the smaller (saphenous) nerve. Patients undergoing ankle fusion or fracture surgery at Wake Forest University typically have a nerve block catheter placed next to the sciatic nerve to give local anesthetic (numbing medicine) for 24-72 hours. In addition, a single injection of local anesthetic is usually performed to block the saphenous nerve for 12-16 hours postoperatively.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsI-Flow

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 22, 2010
Enrollment StartJul 1, 2010
Primary CompletionSep 7, 2017
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 15.9 years ago

Interventions

0.2% ropivacainedevice

0.2% ropivacaine by elastomeric infusion pump at 5ml/h started within 6h of catheter placement

salinedrug

saline (control) by elastomeric infusion pump at 5ml/h started within 6h of catheter placement